C. Terret

5.1k total citations · 2 hit papers
142 papers, 3.4k citations indexed

About

C. Terret is a scholar working on Aerospace Engineering, Electrical and Electronic Engineering and Oncology. According to data from OpenAlex, C. Terret has authored 142 papers receiving a total of 3.4k indexed citations (citations by other indexed papers that have themselves been cited), including 47 papers in Aerospace Engineering, 46 papers in Electrical and Electronic Engineering and 45 papers in Oncology. Recurrent topics in C. Terret's work include Antenna Design and Analysis (40 papers), Microwave Engineering and Waveguides (36 papers) and Advanced Antenna and Metasurface Technologies (34 papers). C. Terret is often cited by papers focused on Antenna Design and Analysis (40 papers), Microwave Engineering and Waveguides (36 papers) and Advanced Antenna and Metasurface Technologies (34 papers). C. Terret collaborates with scholars based in France, United States and Switzerland. C. Terret's co-authors include G. Albrand, J.P. Daniel, Riccardo A. Audisio, Ala Sharaiha, Jean‐Pierre Droz, K. Mahdjoubi, Jean Pierre Droz, Gilbert B. Zulian, Mohamed Himdi and Philippe Pouliguen and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Cancer Research.

In The Last Decade

C. Terret

132 papers receiving 3.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Screening tools for multidimensional health problems warranting a geriatric assessment in older cancer patients: an update on SIOG recommendations

2014 494 citations Lore Decoster, C. Terret et al. Annals of Oncology profile →
Screening for Vulnerability in Older Cancer Patients: The ONCODAGE Prospective Multicenter Cohort Study

2014 368 citations Pierre Soubeyran, Carine Bellera et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
C. Terret France	28	1.3k	935	633	530	520	142	3.4k
Euan Walpole Australia	32	3.8k 3.0×	46 0.0×	273 0.4×	77 0.1×	306 0.6×	129	6.0k
Wilfried De Neve Belgium	57	1.4k 1.1×	112 0.1×	26 0.0×	206 0.4×	102 0.2×	291	9.6k
Stephanie Daignault United States	36	1.2k 1.0×	48 0.1×	56 0.1×	147 0.3×	64 0.1×	123	5.1k
Anne‐Marie C. Dingemans Netherlands	54	4.9k 3.9×	143 0.2×	23 0.0×	774 1.5×	130 0.3×	368	10.2k
Beth M. Beadle United States	41	1.7k 1.4×	54 0.1×	37 0.1×	384 0.7×	49 0.1×	195	5.5k
Lidia Strigari Italy	38	999 0.8×	35 0.0×	38 0.1×	256 0.5×	59 0.1×	282	5.7k
Michael Hughes Australia	21	1.2k 0.9×	15 0.0×	111 0.2×	39 0.1×	133 0.3×	68	3.1k
Miklos Pless Switzerland	34	3.2k 2.5×	52 0.1×	28 0.0×	214 0.4×	38 0.1×	140	5.3k
Lars Bastholt Denmark	42	4.2k 3.3×	11 0.0×	125 0.2×	141 0.3×	154 0.3×	183	8.3k
Reza J. Mehran United States	45	1.4k 1.1×	16 0.0×	103 0.2×	122 0.2×	211 0.4×	276	6.6k

Countries citing papers authored by C. Terret

Since Specialization

Citations

This map shows the geographic impact of C. Terret's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C. Terret with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C. Terret more than expected).

Fields of papers citing papers by C. Terret

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C. Terret. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C. Terret. The network helps show where C. Terret may publish in the future.

Co-authorship network of co-authors of C. Terret

This figure shows the co-authorship network connecting the top 25 collaborators of C. Terret. A scholar is included among the top collaborators of C. Terret based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with C. Terret. C. Terret is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Corbaux, Pauline, Armelle Vinceneux, Hélène Vanacker, et al.. (2024). Patients’ selection and trial matching in early-phase oncology clinical trials. Critical Reviews in Oncology/Hematology. 196. 104307–104307. 5 indexed citations

Gomez‐Roca, Carlos, Sylvie Chabaud, Céline Rodriguez, et al.. (2024). The CSF-1R inhibitor pexidartinib affects FLT3-dependent DC differentiation and may antagonize durvalumab effect in patients with advanced cancers. Science Translational Medicine. 16(731). eadd1834–eadd1834. 32 indexed citations

Terret, C., Camille Schiffler, Hélène Vanacker, et al.. (2024). Xevinapant Combined with Pembrolizumab in Patients with Advanced, Pretreated, Colorectal and Pancreatic Cancer: Results of the Phase Ib/II CATRIPCA Trial. Clinical Cancer Research. 30(10). 2111–2120. 3 indexed citations

François, Éric, Nicolas Magné, Rabia Boulahssass, et al.. (2024). Short course radiotherapy versus radiochemotherapy for locally advanced rectal cancers in the elderly (UNICANCER PRODIGE 42/GERICO 12 study): Quality of life and comprehensive geriatric assessment. Radiotherapy and Oncology. 193. 110144–110144.

Corbaux, Pauline, C. Terret, Claire Cropet, et al.. (2023). Association of chemotherapy and comorbidities with overall survival in elderly patients with early breast cancer: a French population-based propensity score-matched analysis. International Journal of Clinical Oncology. 28(3). 371–381. 2 indexed citations

Delrieu, Lidia, et al.. (2021). Interest and preferences for physical activity programming and counselling among cancer patients aged over 70 years receiving oncological treatments. European Journal of Cancer Care. 31(1). e13527–e13527. 3 indexed citations

Nicolas‐Virelizier, Emmanuelle, Chiara Russo, Olivia Pérol, et al.. (2021). Individualised physical activity programme in patients over 65 years with haematological malignancies (OCAPI): protocol for a single-arm feasibility trial. BMJ Open. 11(6). e046409–e046409. 1 indexed citations

Fouchardière, Christelle de la, Lore Decoster, Emmanuelle Samalin, et al.. (2021). Advanced oesophago-gastric adenocarcinoma in older patients in the era of immunotherapy. A review of the literature. Cancer Treatment Reviews. 100. 102289–102289. 5 indexed citations

Jhaveri, Komal, Dejan Juric, Sara Cresta, et al.. (2020). LBA1 Interim results of a phase I/Ib study of LSZ102, an oral selective estrogen receptor degrader (SERD), in combination with ribociclib (RIB) or alpelisib (ALP) in patients with ER+ breast cancer (BC) who had progressed after endocrine therapy (ET). Annals of Oncology. 31. S62–S62. 7 indexed citations

10.

Terret, C. & Chiara Russo. (2018). Pharmacotherapeutic Management of Breast Cancer in Elderly Patients: The Promise of Novel Agents. Drugs & Aging. 35(2). 93–115. 7 indexed citations

11.

Cassier, Philippe A., Christelle de la Fouchardière, Pierre Guibert, et al.. (2017). Actionable molecular alterations in advanced biliary tract carcinomas: Preliminary data from the ProfiLER program (NCT01774409). Annals of Oncology. 28. v247–v247. 1 indexed citations

12.

Soubeyran, Pierre, C. Terret, Carine Bellera, et al.. (2016). Role of geriatric intervention in the treatment of older patients with cancer: rationale and design of a phase III multicenter trial. BMC Cancer. 16(1). 932–932. 21 indexed citations

13.

Tremblay, Dominique, et al.. (2012). Integrated oncogeriatric approach: a systematic review of the literature using concept analysis. BMJ Open. 2(6). e001483–e001483. 26 indexed citations

14.

Culine, Stéphane, C. Terret, Didier Cupissol, et al.. (2012). Risk-adapted, dose escalation study of weekly docetaxel in the first-line treatment of elderly patients with advanced cancer. Journal of Geriatric Oncology. 4(2). 122–127. 6 indexed citations

15.

Terret, C. & Jean‐Pierre Droz. (2011). Quality of Life in Elderly Patients with Urological Malignancies — A Review of Standard Questionnaires. European Oncology & Haematology. 7(3). 168–168. 1 indexed citations

16.

Terret, C. & J P Droz. (2009). Définition et présentation de la cancérologie du sujet âgé. Progrès en Urologie. 19. S75–S79. 7 indexed citations

17.

Surbone, Antonella, Marjorie Kagawa‐Singer, C. Terret, & Lea Baider. (2006). The illness trajectory of elderly cancer patients across cultures: SIOG position paper. Annals of Oncology. 18(4). 633–638. 86 indexed citations

18.

Terret, C., Gilbert B. Zulian, & Jean‐Pierre Droz. (2004). Statements on the interdependence between the oncologist and the geriatrician in geriatric oncology. Critical Reviews in Oncology/Hematology. 52(2). 127–133. 37 indexed citations

19.

Terret, C.. (2000). Dose and time dependencies of 5-fluorouracil pharmacokinetics. Clinical Pharmacology & Therapeutics. 68(3). 270–279. 50 indexed citations

20.

Terret, C., C. Couteau, & Jean‐Pierre Armand. (1996). CPT-11: the European clinical development.. PubMed. 6(3). 152–7. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact